Janux Therapeutics (NASDAQ: JANX) 30-day option implied volatility is at 160; compared to its 52-week range of 67 to 201 into Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC. Call put ratio 1 call to 2.8 puts.